AMGN compared with SANA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

SANASana Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

SANASana Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

Q3 FY25±3.7%▲+7.81%×2.11

SANA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±28.3%▲+4.99%×0.18

May 12 '26±29.1%▼−8.43%×0.29

= impliedAMGN realized, solidSANA realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

Q1 FY26

±23.8%

▼−2.80%

×0.12

Q3 FY25±28.0%▲+0.99%×0.04

AMGNAmgen Inc

465.45· pre 464.01· delayed

Mkt cap$251.6BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

SANASana Biotechnology, Inc.

2.40· pre 2.49· delayed

Pre-marketNov 3 '26delayed

Mkt cap$718.5MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

AMGNAmgen Inc

SANASana Biotechnology, Inc.

465.45pre 464.01delayed

Price

2.40pre 2.49delayed

$251.6B

Mkt cap

$718.5M

Q2 FY26$10.1B

Revenue

—

FY25$36.8B

Revenue

—

AMGN465.45vsSANA2.40Pre-marketNov 3 '26delayed